Molecular Imaging Market: Increasing Application of Integrated PET-CT and PET-MR Devices to Drive Revenue Growth: Global Industry Analysis 2012-2016 and Opportunity Assessment 2017-2027
- Healthcare, Pharmaceuticals and Medical devices
- No. of Pages: 400
- Published: 2017-09-19
- Report Code: REP-GB-724
-
Format:
An Incisive, In-depth Analysis on the Molecular Imaging Market
This study offers a comprehensive, 360 degree analysis on the Molecular Imaging market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Molecular Imaging market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Siemens AG and Hitachi Medical Corporation are among top 10 key players holding more than 55% revenue share in the global molecular imaging market
The top 10 key players contributed approximately 58% revenue share to the global molecular imaging market in 2016. The remaining players contributed approximately 42% revenue share to the global molecular imaging market in 2016. The top seven key players in the market contributed more than US$ 1,600 Mn, while other player’s contribution in the global molecular imaging market in 2016 was more than US$ 1,200 Mn. Around 52%, and 28% revenue is contributed by tier1 and tier 2 players respectively, while, 20% revenue is contributed by tier 3 players which are local/regional manufacturers.
With more than 11% CAGR, PET-MR segment by modality type is ahead of all other segments in terms of CAGR
SPECT segment dominated the global molecular imaging market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. PET-CT segment is expected to be the most lucrative among all modality, with attractiveness index of 2.2. SPECT segment is expected to be the second largest market for molecular imaging market, with market share Index of 1.5. MR spectroscopy and software segments remain third-largest market and represents market share Index of 1.0.
Insufficient supply of molecular isotopes likely to hamper the growth of the North America molecular imaging market
The lesser availability and insufficient supply of molecular isotopes, which is required for molecular imaging devices, may restrain the growth of the global molecular imaging market in North America region over forecast period. For instance, technetium and molybdenum that support majority of SPECT procedures in cardiology, have been facing several disruptions in supply since last few years. The reactors from Canada which supply the molecular isotopes got permanently shut down in 2016 due to safety concerns.
Inadequate reimbursement policies expected to create a negative impact on the APEJ market for molecular imaging
Molecular imaging devices are expensive in APEJ region and therefore diagnosis cost is also unaffordable. Absence of health insurance and limited government support policies that cover diagnosis with high end technology devices, such as PET-CT and PET-MR in developing countries, such as India and China are adding to the woes in the present situation. The absence of social health insurance along with exclusionary provision of private health insurance schemes is a major factor limiting the growth of the molecular imaging market.
Product recalls and safety concerns are the major hindrances in the Western Europe molecular imaging market
Adverse events associated with the use of molecular imaging devices in evaluation, diagnosis, staging, restaging and follow up on lesions, diseases and organ dysfunctions, such as cancer, cardiovascular disease and brain dysfunction, may hamper the demand for devices and restrain the growth of the Western Europe market. For instance, in 2014, the GE Healthcare recalled CT and PET-CT devices to address safety concerns under FDA class-II regulation’s service manuals for a number of CT and PET CT scanners to update an incorrect torque value.
Japan market for molecular imaging likely to face obstacle due to short life of radiopharmaceuticals
Imaging and diagnostic devices, such as SPECT and PET utilize radioisotope tracers in order to achieve better imaging capabilities and give more specific information about organ function and dysfunction. Fluoro-deoxy glucose (FDG) is incorporated with fluorine-18 and acts as the most commonly used tracer in PET imaging. The radiotracer has a half-life of just about two hours, which limits its utility in the diagnostic imaging industry. This has led to a decrease in the utilization of FDG, which has affected the PET based imaging market. Also, limited availability of the radiotracer FDG would also contribute towards the declining growth of the molecular imaging market in the region.
In a recent publication titled “Molecular Imaging Market: Global Industry Analysis (2012 –2016) and Opportunity Assessment (2017 – 2027),” we have considered the weighted average pricing for different molecular imagingdevices. This has been done on the basis of information gathered from reliable secondarysources validated through marketplace discussions and private company databases. We have also observed that pricing values of molecular imaging devices have been counter validated with market experts through primary research along with regional variations in price levels. It is very necessary to note that this pricing analysis does not include margins analysis from the manufacturers end. Currency fluctuations have not been taken into account and the analysis is static in nature. It also rules out impact of extreme events in specific countries. Weighted averaging of high-end and low-end pricing has been done to rule out effect of extreme values and brand weightages. A demand-supply gap analysis has been performed involving both marketplace discussion and desk research to determine pricing premiums.
Report Structure
This report begins with the market definition, followed by definitions of the different molecular imaging devices. The market dynamics section includes Future Market Insights’ analysis on key trends, drivers, restraints, opportunities and macro-economic factors that are influencing the growth of the global molecular imaging market and key regulations for medical devices. Also, the pricing analysis of different products in the segment is mentioned for upcoming molecular imaging products. The report analyses the market on the basis of application and presents forecast by value for the next 10 years. The global molecular imaging market segments such as modality type, application, end-user and region, have been analysed on Basis Point Share (BPS) to understand the individual segment’s respective contributions to market growth. This detailed level of information is important for identifying various key trends in the global molecular imaging market.
At the end of the report, list of key players have been provided who are engaged in the market for global molecular imaging. This section is preferably designed to provide clients with an aim and detailed comparative assessment of key providers specific to the market segment in the global molecular imaging market and the potential players. In addition, this section includes company details, company overview, key developments and market strategies of the profiled key player active in the global molecular imaging market. Detailed profiles of molecular imaging devices manufacturers are also included in the scope of the report to evaluate their strategies in a bid to sustain in this competitive market.
Global Molecular Imaging Market: Segmentation
|
Modality Type |
End User |
Application |
Region |
|---|---|---|---|
|
|
|
|
Research Methodology
Macro-economic indicators such as molecular imaging market outlook, gross domestic product and others has been considered to arrive at the indicated market numbers. Bottom-up approach has been used to assess market numbers, while top-down approach has been used to counter-validate the reached numbers for molecular imaging Market numbers. The analysts of Future Market Insights have performed systematic exhaustive secondary research to analyse the required data points to arrive at the overall market numbers. Our analysts have developed questionnaires for each node in the value chain to extract the required market information through primary research interviews. While conducting interviews we have used distinguished essential resources. Data is validated by triangulation method, wherein secondary, primary and Future Market Insight’s analysis have contributed to the final data.
Molecular Imaging Market Reports - Table of Contents
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
19. Research Methodology
Molecular Imaging Market Reports - List of Tables
Table 01: North America Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 02: North America Molecular Imaging Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type
Table 03: North America Molecular Imaging Market Size Volume (Units) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type
Table 04: North America Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application
Table 05: North America Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User
Table 06: Latin America Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 07: Latin America Molecular Imaging Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type
Table 08: Latin America Molecular Imaging Market Size Volume (Units) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type
Table 09: Latin America Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application
Table 10: Latin America Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User
Table 11: Western Europe Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 12: Western Europe Molecular Imaging Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type
Table 13: Western Europe Molecular Imaging Market Size Volume (Units) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type
Table 14: Western Europe Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application
Table 15: Western Europe Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User
Table 16: Eastern Europe Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 17: Eastern Europe Molecular Imaging Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type
Table 18: Eastern Europe Molecular Imaging Market Size Volume (Units) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type
Table 19: Eastern Europe Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application
Table 20: Eastern Europe Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User
Table 21: APEJ Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 22: APEJ Molecular Imaging Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type
Table 23: APEJ Molecular Imaging Market Size Volume (Units) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type
Table 24: APEJ Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application
Table 25: APEJ Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User
Table 26: Japan Molecular Imaging Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type
Table 27: Japan Molecular Imaging Market Size Volume (Units) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type
Table 28: Japan Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application
Table 29: Japan Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User
Table 30: MEA Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 31: MEA Molecular Imaging Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type
Table 32: MEA Molecular Imaging Market Size Volume (Units) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type
Table 33: MEA Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application
Table 34: MEA Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User
Table 35: Global Molecular Imaging Market Size (US$ Mn) Forecast By Region, 2012–2017
Table 36: Global Molecular Imaging Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type
Table 37: Global Molecular Imaging Market Size Volume (Units) Analysis-2012–2016 and Forecast 2017–2027, By Modality Type
Table 38: Global Molecular Imaging Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application
Table 39: Global Molecular Imaging Market Size (US$ Mn) Forecast By End User, 2012–2017
Molecular Imaging Market Reports - List of Figures
Figure 01: North America Molecular Imaging Market Size Analysis, 2012–2016
Figure 02: North America Molecular Imaging Market Forecast, 2017–2027
Figure 03: U.S. Molecular Imaging Market Size Analysis, 2012–2016
Figure 04: U.S. Molecular Imaging Market Forecast, 2017–2027
Figure 05: Canada Molecular Imaging Market Size Analysis, 2012–2016
Figure 06: Canada Molecular Imaging Market Forecast, 2017–2027
Figure 07: North America Molecular Imaging Market Attractiveness Analysis By Country, 2017–2027
Figure 08: North America PET Molecular Imaging Market Size Analysis, 2012–2016
Figure 09: North America PET Molecular Imaging Market Forecast, 2017–2027
Figure 10: North America PET-CT Molecular Imaging Market Size Analysis, 2012–2016
Figure 11: North America PET-CT Molecular Imaging Market Forecast, 2017–2027
Figure 12: North America PET-MR Molecular Imaging Market Size Analysis, 2012–2016
Figure 13: North America PET-MR Molecular Imaging Market Forecast, 2017–2027
Figure 14: North America SPECT Molecular Imaging Market Size Analysis, 2012–2016
Figure 15: North America SPECT Molecular Imaging Market Forecast, 2017–2027
Figure 16: North America Magnetic Resonance Spectroscopy Molecular Imaging Market Size Analysis, 2012–2016
Figure 17: North America Magnetic Resonance Spectroscopy Molecular Imaging Market Forecast, 2017–2027
Figure 18: North America Molecular Ultrasound Imaging Molecular Imaging Market Size Analysis, 2012–2016
Figure 19: North America Molecular Ultrasound Imaging Molecular Imaging Market Forecast, 2017–2027
Figure 20: North America Molecular Imaging Software Market Size Analysis, 2012–2016
Figure 21: North America Molecular Imaging Software Market Forecast, 2017–2027
Figure 22: North America Molecular Imaging Market Attractiveness Analysis By Modality, 2017–2027
Figure 23: North America Cardiology Molecular Imaging Market Size Analysis, 2012–2016
Figure 24: North America Cardiology Molecular Imaging Market Forecast, 2017–2027
Figure 25: North America Oncology Molecular Imaging Market Size Analysis, 2012–2016
Figure 26: North America Oncology Molecular Imaging Market Forecast, 2017–2027
Figure 27: North America Gastrointestinal Disorders Molecular Imaging Market Size Analysis, 2012–2016
Figure 28: North America Gastrointestinal Disorders Molecular Imaging Market Forecast, 2017–2027
Figure 29: North America Neurology Disorders Molecular Imaging Market Size Analysis, 2012–2016
Figure 30: North America Neurology Disorders Molecular Imaging Market Forecast, 2017–2027
Figure 31: North America Other Molecular Imaging Market Size Analysis, 2012–2016
Figure 32: North America Other Molecular Imaging Market Forecast, 2017–2027
Figure 33: North America Molecular Imaging Market Attractiveness Analysis By Application, 2017–2027
Figure 34: North America Hospital Molecular Imaging Market Size Analysis, 2012–2016
Figure 35: North America Hospital Molecular Imaging Market Forecast, 2017–2027
Figure 36: North America Ambulatory Surgical Center Molecular Imaging Market Size Analysis, 2012–2016
Figure 37: North America Ambulatory Surgical Center Molecular Imaging Market Forecast, 2017–2027
Figure 38: North America Diagnostics Imaging Center Molecular Imaging Market Size Analysis, 2012–2016
Figure 39: North America Diagnostics Imaging Center Molecular Imaging Market Forecast, 2017–2027
Figure 40: North America Molecular Imaging Market Attractiveness Analysis By End User, 2017–2027
Figure 41: Latin America Molecular Imaging Market Size Analysis, 2012–2016
Figure 42: Latin America Molecular Imaging Market Forecast, 2017–2027
Figure 43: Brazil Molecular Imaging Market Size Analysis, 2012–2016
Figure 44: Brazil Molecular Imaging Market Forecast, 2017–2027
Figure 45: Mexico Molecular Imaging Market Size Analysis, 2012–2016
Figure 46: Mexico Molecular Imaging Market Forecast, 2017–2027
Figure 47: Rest of Latin America Molecular Imaging Market Size Analysis, 2012–2016
Figure 48: Rest of Latin America Molecular Imaging Market Forecast, 2017–2027
Figure 49: Latin America Molecular Imaging Market Attractiveness Analysis By Country, 2017–2027
Figure 50: Latin America PET Molecular Imaging Market Size Analysis, 2012–2016
Figure 51: Latin America PET Molecular Imaging Market Forecast, 2017–2027
Figure 52: Latin America PET-CT Molecular Imaging Market Size Analysis, 2012–2016
Figure 53: Latin America PET-CT Molecular Imaging Market Forecast, 2017–2027
Figure 54: Latin America PET-MR Molecular Imaging Market Size Analysis, 2012–2016
Figure 55: Latin America PET-MR Molecular Imaging Market Forecast, 2017–2027
Figure 56: Latin America SPECT Molecular Imaging Market Size Analysis, 2012–2016
Figure 57: Latin America SPECT Molecular Imaging Market Forecast, 2017–2027
Figure 58: Latin America Magnetic Resonance Spectroscopy Molecular Imaging Market Size Analysis, 2012–2016
Figure 59: Latin America Magnetic Resonance Spectroscopy Molecular Imaging Market Forecast, 2017–2027
Figure 60: Latin America Molecular Ultrasound Imaging Molecular Imaging Market Size Analysis, 2012–2016
Figure 61: Latin America Molecular Ultrasound Imaging Molecular Imaging Market Forecast, 2017–2027
Figure 62: Latin America Molecular Imaging Software Market Size Analysis, 2012–2016
Figure 63: Latin America Molecular Imaging Software Market Forecast, 2017–2027
Figure 64: Latin America Molecular Imaging Market Attractiveness Analysis By Modality, 2017–2027
Figure 65: Latin America Cardiology Molecular Imaging Market Size Analysis, 2012–2016
Figure 66: Latin America Cardiology Molecular Imaging Market Forecast, 2017–2027
Figure 67: Latin America Oncology Molecular Imaging Market Size Analysis, 2012–2016
Figure 68: Latin America Oncology Molecular Imaging Market Forecast, 2017–2027
Figure 69: Latin America Gastrointestinal Disorders Molecular Imaging Market Size Analysis, 2012–2016
Figure 70: Latin America Gastrointestinal Disorders Molecular Imaging Market Forecast, 2017–2027
Figure 71: Latin America Neurology Disorders Molecular Imaging Market Size Analysis, 2012–2016
Figure 72: Latin America Neurology Disorders Molecular Imaging Market Forecast, 2017–2027
Figure 73: Latin America Other Molecular Imaging Market Size Analysis, 2012–2016
Figure 74: Latin America Other Molecular Imaging Market Forecast, 2017–2027
Figure 75: Latin America Molecular Imaging Market Attractiveness Analysis By Application, 2017–2027
Figure 76: Latin America Hospital Molecular Imaging Market Size Analysis, 2012–2016
Figure 77: Latin America Hospital Molecular Imaging Market Forecast, 2017–2027
Figure 78: Latin America Ambulatory Surgical Center Molecular Imaging Market Size Analysis, 2012–2016
Figure 79: Latin America Ambulatory Surgical Center Molecular Imaging Market Forecast, 2017–2027
Figure 80: Latin America Diagnostics Imaging Center Molecular Imaging Market Size Analysis, 2012–2016
Figure 81: Latin America Diagnostics Imaging Center Molecular Imaging Market Forecast, 2017–2027
Figure 82: Latin America Molecular Imaging Market Attractiveness Analysis By End User, 2017–2027
Figure 83: Western Europe Molecular Imaging Market Size Analysis, 2012–2016
Figure 84: Western Europe Molecular Imaging Market Forecast, 2017–2027
Figure 85: Germany Molecular Imaging Market Size Analysis, 2012–2016
Figure 86: Germany Molecular Imaging Market Forecast, 2017–2027
Figure 87: Italy Molecular Imaging Market Size Analysis, 2012–2016
Figure 88: Italy Molecular Imaging Market Forecast, 2017–2027
Figure 89: France Molecular Imaging Market Size Analysis, 2012–2016
Figure 90: France Molecular Imaging Market Forecast, 2017–2027
Figure 91: Spain Molecular Imaging Market Size Analysis, 2012–2016
Figure 92: Spain Molecular Imaging Market Forecast, 2017–2027
Figure 93: U.K. Molecular Imaging Market Size Analysis, 2012–2016
Figure 94: U.K. Molecular Imaging Market Forecast, 2017–2027
Figure 95: BENELUX Molecular Imaging Market Size Analysis, 2012–2016
Figure 96: BENELUX Molecular Imaging Market Forecast, 2017–2027
Figure 97: Rest of Western Europe Molecular Imaging Market Size Analysis, 2012–2016
Figure 98: Rest of Western Europe Molecular Imaging Market Forecast, 2017–2027
Figure 99: Western Europe Molecular Imaging Market Attractiveness Analysis By Country, 2017–2027
Figure 100: Western Europe PET Molecular Imaging Market Size Analysis, 2012–2016
Figure 101: Western Europe PET Molecular Imaging Market Forecast, 2017–2027
Figure 102: Western Europe PET-CT Molecular Imaging Market Size Analysis, 2012–2016
Figure 103: Western Europe PET-CT Molecular Imaging Market Forecast, 2017–2027
Figure 104: Western Europe PET-MR Molecular Imaging Market Size Analysis, 2012–2016
Figure 105: Western Europe PET-MR Molecular Imaging Market Forecast, 2017–2027
Figure 106: Western Europe SPECT Molecular Imaging Market Size Analysis, 2012–2016
Figure 107: Western Europe SPECT Molecular Imaging Market Forecast, 2017–2027
Figure 108: Western Europe Magnetic Resonance Spectroscopy Molecular Imaging Market Size Analysis, 2012–2016
Figure 109: Western Europe Magnetic Resonance Spectroscopy Molecular Imaging Market Forecast, 2017–2027
Figure 110: Western Europe Molecular Ultrasound Imaging Molecular Imaging Market Size Analysis, 2012–2016
Figure 111: Western Europe Molecular Ultrasound Imaging Molecular Imaging Market Forecast, 2017–2027
Figure 112: Western Europe Molecular Imaging Software Market Size Analysis, 2012–2016
Figure 113: Western Europe Molecular Imaging Software Market Forecast, 2017–2027
Figure 114: Western Europe Molecular Imaging Market Attractiveness Analysis By Modality, 2017–2027
Figure 115: Western Europe Cardiology Molecular Imaging Market Size Analysis, 2012–2016
Figure 116: Western Europe Cardiology Molecular Imaging Market Forecast, 2017–2027
Figure 117: Western Europe Oncology Molecular Imaging Market Size Analysis, 2012–2016
Figure 118: Western Europe Oncology Molecular Imaging Market Forecast, 2017–2027
Figure 119: Western Europe Gastrointestinal Disorders Molecular Imaging Market Size Analysis, 2012–2016
Figure 120: Western Europe Gastrointestinal Disorders Molecular Imaging Market Forecast, 2017–2027
Figure 121: Western Europe Neurology Disorders Molecular Imaging Market Size Analysis, 2012–2016
Figure 122: Western Europe Neurology Disorders Molecular Imaging Market Forecast, 2017–2027
Figure 123: Western Europe Other Molecular Imaging Market Size Analysis, 2012–2016
Figure 124: Western Europe Other Molecular Imaging Market Forecast, 2017–2027
Figure 125: Western Europe Molecular Imaging Market Attractiveness Analysis By Application, 2017–2027
Figure 126: Western Europe Hospital Molecular Imaging Market Size Analysis, 2012–2016
Figure 127: Western Europe Hospital Molecular Imaging Market Forecast, 2017–2027
Figure 128: Western Europe Ambulatory Surgical Center Molecular Imaging Market Size Analysis, 2012–2016
Figure 129: Western Europe Ambulatory Surgical Center Molecular Imaging Market Forecast, 2017–2027
Figure 130: Western Europe Diagnostics Imaging Center Molecular Imaging Market Size Analysis, 2012–2016
Figure 131: Western Europe Diagnostics Imaging Center Molecular Imaging Market Forecast, 2017–2027
Figure 132: Western Europe Molecular Imaging Market Attractiveness Analysis By End User, 2017–2027
Figure 133: Eastern Europe Molecular Imaging Market Size Analysis, 2012–2016
Figure 134: Eastern Europe Molecular Imaging Market Forecast, 2017–2027
Figure 135: Russia Molecular Imaging Market Size Analysis, 2012–2016
Figure 136: Russia Molecular Imaging Market Forecast, 2017–2027
Figure 137: Poland Molecular Imaging Market Size Analysis, 2012–2016
Figure 138: Poland Molecular Imaging Market Forecast, 2017–2027
Figure 139: Rest of Eastern Europe Molecular Imaging Market Size Analysis, 2012–2016
Figure 140: Rest of Eastern Europe Molecular Imaging Market Forecast, 2017–2027
Figure 141: Eastern Europe Molecular Imaging Market Attractiveness Analysis By Country, 2017–2027
Figure 142: Eastern Europe PET Molecular Imaging Market Size Analysis, 2012–2016
Figure 143: Eastern Europe PET Molecular Imaging Market Forecast, 2017–2027
Figure 144: Eastern Europe PET-CT Molecular Imaging Market Size Analysis, 2012–2016
Figure 145: Eastern Europe PET-CT Molecular Imaging Market Forecast, 2017–2027
Figure 146: Eastern Europe PET-MR Molecular Imaging Market Size Analysis, 2012–2016
Figure 147: Eastern Europe PET-MR Molecular Imaging Market Forecast, 2017–2027
Figure 148: Eastern Europe SPECT Molecular Imaging Market Size Analysis, 2012–2016
Figure 149: Eastern Europe SPECT Molecular Imaging Market Forecast, 2017–2027
Figure 150: Eastern Europe Magnetic Resonance Spectroscopy Molecular Imaging Market Size Analysis, 2012–2016
Figure 151: Eastern Europe Magnetic Resonance Spectroscopy Molecular Imaging Market Forecast, 2017–2027
Figure 152: Eastern Europe Molecular Ultrasound Imaging Molecular Imaging Market Size Analysis, 2012–2016
Figure 153: Eastern Europe Molecular Ultrasound Imaging Molecular Imaging Market Forecast, 2017–2027
Figure 154: Eastern Europe Molecular Imaging Software Market Size Analysis, 2012–2016
Figure 155: Eastern Europe Molecular Imaging Software Market Forecast, 2017–2027
Figure 156: Eastern Europe Molecular Imaging Market Attractiveness Analysis By Modality, 2017–2027
Figure 157: Eastern Europe Cardiology Molecular Imaging Market Size Analysis, 2012–2016
Figure 158: Eastern Europe Cardiology Molecular Imaging Market Forecast, 2017–2027
Figure 159: Eastern Europe Oncology Molecular Imaging Market Size Analysis, 2012–2016
Figure 160: Eastern Europe Oncology Molecular Imaging Market Forecast, 2017–2027
Figure 161: Eastern Europe Gastrointestinal Disorders Molecular Imaging Market Size Analysis, 2012–2016
Figure 162: Eastern Europe Gastrointestinal Disorders Molecular Imaging Market Forecast, 2017–2027
Figure 163: Eastern Europe Neurology Disorders Molecular Imaging Market Size Analysis, 2012–2016
Figure 164: Eastern Europe Neurology Disorders Molecular Imaging Market Forecast, 2017–2027
Figure 165: Eastern Europe Other Molecular Imaging Market Size Analysis, 2012–2016
Figure 166: Eastern Europe Other Molecular Imaging Market Forecast, 2017–2027
Figure 167: Eastern Europe Molecular Imaging Market Attractiveness Analysis By Application, 2017–2027
Figure 168: Eastern Europe Hospital Molecular Imaging Market Size Analysis, 2012–2016
Figure 169: Eastern Europe Hospital Molecular Imaging Market Forecast, 2017–2027
Figure 170: Eastern Europe Ambulatory Surgical Center Molecular Imaging Market Size Analysis, 2012–2016
Figure 171: Eastern Europe Ambulatory Surgical Center Molecular Imaging Market Forecast, 2017–2027
Figure 172: Eastern Europe Diagnostics Imaging Center Molecular Imaging Market Size Analysis, 2012–2016
Figure 173: Eastern Europe Diagnostics Imaging Center Molecular Imaging Market Forecast, 2017–2027
Figure 174: Eastern Europe Molecular Imaging Market Attractiveness Analysis By End User, 2017–2027
Figure 175: APEJ Molecular Imaging Market Size Analysis, 2012–2016
Figure 176: APEJ Molecular Imaging Market Forecast, 2017–2027
Figure 177: China Molecular Imaging Market Size Analysis, 2012–2016
Figure 178: China Molecular Imaging Market Forecast, 2017–2027
Figure 179: India Molecular Imaging Market Size Analysis, 2012–2016
Figure 180: India Molecular Imaging Market Forecast, 2017–2027
Figure 181: Australia and New Zealand Molecular Imaging Market Size Analysis, 2012–2016
Figure 182: Australia and New Zealand Molecular Imaging Market Forecast, 2017–2027
Figure 183: ASEAN Molecular Imaging Market Size Analysis, 2012–2016
Figure 184: ASEAN Molecular Imaging Market Forecast, 2017–2027
Figure 185: Rest of APEJ Molecular Imaging Market Size Analysis, 2012–2016
Figure 186: Rest of APEJ Molecular Imaging Market Forecast, 2017–2027
Figure 187: APEJ Molecular Imaging Market Attractiveness Analysis By Country, 2017–2027
Figure 188: APEJ PET Molecular Imaging Market Size Analysis, 2012–2016
Figure 189: APEJ PET Molecular Imaging Market Forecast, 2017–2027
Figure 190: APEJ PET-CT Molecular Imaging Market Size Analysis, 2012–2016
Figure 191: APEJ PET-CT Molecular Imaging Market Forecast, 2017–2027
Figure 192: APEJ PET-MR Molecular Imaging Market Size Analysis, 2012–2016
Figure 193: APEJ PET-MR Molecular Imaging Market Forecast, 2017–2027
Figure 194: APEJ SPECT Molecular Imaging Market Size Analysis, 2012–2016
Figure 195: APEJ SPECT Molecular Imaging Market Forecast, 2017–2027
Figure 196: APEJ Magnetic Resonance Spectroscopy Molecular Imaging Market Size Analysis, 2012–2016
Figure 197: APEJ Magnetic Resonance Spectroscopy Molecular Imaging Market Forecast, 2017–2027
Figure 198: APEJ Molecular Ultrasound Imaging Molecular Imaging Market Size Analysis, 2012–2016
Figure 199: APEJ Molecular Ultrasound Imaging Molecular Imaging Market Forecast, 2017–2027
Figure 200: APEJ Molecular Imaging Software Market Size Analysis, 2012–2016
Figure 201: APEJ Molecular Imaging Software Market Forecast, 2017–2027
Figure 202: APEJ Molecular Imaging Market Attractiveness Analysis By Modality, 2017–2027
Figure 203: APEJ Cardiology Molecular Imaging Market Size Analysis, 2012–2016
Figure 204: APEJ Cardiology Molecular Imaging Market Forecast, 2017–2027
Figure 205: APEJ Oncology Molecular Imaging Market Size Analysis, 2012–2016
Figure 206: APEJ Oncology Molecular Imaging Market Forecast, 2017–2027
Figure 207: APEJ Gastrointestinal Disorders Molecular Imaging Market Size Analysis, 2012–2016
Figure 208: APEJ Gastrointestinal Disorders Molecular Imaging Market Forecast, 2017–2027
Figure 209: APEJ Neurology Disorders Molecular Imaging Market Size Analysis, 2012–2016
Figure 210: APEJ Neurology Disorders Molecular Imaging Market Forecast, 2017–2027
Figure 211: APEJ Other Molecular Imaging Market Size Analysis, 2012–2016
Figure 212: APEJ Other Molecular Imaging Market Forecast, 2017–2027
Figure 213: APEJ Molecular Imaging Market Attractiveness Analysis By Application, 2017–2027
Figure 214: APEJ Hospital Molecular Imaging Market Size Analysis, 2012–2016
Figure 215: APEJ Hospital Molecular Imaging Market Forecast, 2017–2027
Figure 216: APEJ Ambulatory Surgical Center Molecular Imaging Market Size Analysis, 2012–2016
Figure 217: APEJ Ambulatory Surgical Center Molecular Imaging Market Forecast, 2017–2027
Figure 218: APEJ Diagnostics Imaging Center Molecular Imaging Market Size Analysis, 2012–2016
Figure 219: APEJ Diagnostics Imaging Center Molecular Imaging Market Forecast, 2017–2027
Figure 220: APEJ Molecular Imaging Market Attractiveness Analysis By End User, 2017–2027
Figure 221: Japan Molecular Imaging Market Size Analysis, 2012–2016
Figure 222: Japan Molecular Imaging Market Forecast, 2017–2027
Figure 223: Japan PET Molecular Imaging Market Size Analysis, 2012–2016
Figure 224: Japan PET Molecular Imaging Market Forecast, 2017–2027
Figure 225: Japan PET-CT Molecular Imaging Market Size Analysis, 2012–2016
Figure 226: Japan PET-CT Molecular Imaging Market Forecast, 2017–2027
Figure 227: Japan PET-MR Molecular Imaging Market Size Analysis, 2012–2016
Figure 228: Japan PET-MR Molecular Imaging Market Forecast, 2017–2027
Figure 229: Japan SPECT Molecular Imaging Market Size Analysis, 2012–2016
Figure 230: Japan SPECT Molecular Imaging Market Forecast, 2017–2027
Figure 231: Japan Magnetic Resonance Spectroscopy Molecular Imaging Market Size Analysis, 2012–2016
Figure 232: Japan Magnetic Resonance Spectroscopy Molecular Imaging Market Forecast, 2017–2027
Figure 233: Japan Molecular Ultrasound Imaging Molecular Imaging Market Size Analysis, 2012–2016
Figure 234: Japan Molecular Ultrasound Imaging Molecular Imaging Market Forecast, 2017–2027
Figure 235: Japan Molecular Imaging Software Market Size Analysis, 2012–2016
Figure 236: Japan Molecular Imaging Software Market Forecast, 2017–2027
Figure 237: Japan Molecular Imaging Market Attractiveness Analysis By Modality, 2017–2027
Figure 238: Japan Cardiology Molecular Imaging Market Size Analysis, 2012–2016
Figure 239: Japan Cardiology Molecular Imaging Market Forecast, 2017–2027
Figure 240: Japan Oncology Molecular Imaging Market Size Analysis, 2012–2016
Figure 241: Japan Oncology Molecular Imaging Market Forecast, 2017–2027
Figure 242: Japan Gastrointestinal Disorders Molecular Imaging Market Size Analysis, 2012–2016
Figure 243: Japan Gastrointestinal Disorders Molecular Imaging Market Forecast, 2017–2027
Figure 244: Japan Neurology Disorders Molecular Imaging Market Size Analysis, 2012–2016
Figure 245: Japan Neurology Disorders Molecular Imaging Market Forecast, 2017–2027
Figure 246: Japan Other Molecular Imaging Market Size Analysis, 2012–2016
Figure 247: Japan Other Molecular Imaging Market Forecast, 2017–2027
Figure 248: Japan Molecular Imaging Market Attractiveness Analysis By Application, 2017–2027
Figure 249: Japan Hospital Molecular Imaging Market Size Analysis, 2012–2016
Figure 250: Japan Hospital Molecular Imaging Market Forecast, 2017–2027
Figure 251: Japan Ambulatory Surgical Center Molecular Imaging Market Size Analysis, 2012–2016
Figure 252: Japan Ambulatory Surgical Center Molecular Imaging Market Forecast, 2017–2027
Figure 253: Japan Diagnostics Imaging Center Molecular Imaging Market Size Analysis, 2012–2016
Figure 254: Japan Diagnostics Imaging Center Molecular Imaging Market Forecast, 2017–2027
Figure 255: Japan Molecular Imaging Market Attractiveness Analysis By End User, 2017–2027
Figure 256: MEA Molecular Imaging Market Size Analysis, 2012–2016
Figure 257: MEA Molecular Imaging Market Forecast, 2017–2027
Figure 258: GCC Countries Molecular Imaging Market Size Analysis, 2012–2016
Figure 259: GCC Countries Molecular Imaging Market Forecast, 2017–2027
Figure 260: South Africa Molecular Imaging Market Size Analysis, 2012–2016
Figure 261: South Africa Molecular Imaging Market Forecast, 2017–2027
Figure 262: Rest of MEA Molecular Imaging Market Size Analysis, 2012–2016
Figure 263: Rest of MEA Molecular Imaging Market Forecast, 2017–2027
Figure 264: MEA Molecular Imaging Market Attractiveness Analysis By Country, 2017–2027
Figure 265: PET Molecular Imaging Market Size Analysis, 2012–2016
Figure 266: PET Molecular Imaging Market Forecast, 2017–2027
Figure 267: PET-CT Molecular Imaging Market Size Analysis, 2012–2016
Figure 268: PET-CT Molecular Imaging Market Forecast, 2017–2027
Figure 269: PET-MR Molecular Imaging Market Size Analysis, 2012–2016
Figure 270: PET-MR Molecular Imaging Market Forecast, 2017–2027
Figure 271: SPECT Molecular Imaging Market Size Analysis, 2012–2016
Figure 272: SPECT Molecular Imaging Market Forecast, 2017–2027
Figure 273: Magnetic Resonance Spectroscopy Molecular Imaging Market Size Analysis, 2012–2016
Figure 274: Magnetic Resonance Spectroscopy Molecular Imaging Market Forecast, 2017–2027
Figure 275: Molecular Ultrasound Imaging Molecular Imaging Market Size Analysis, 2012–2016
Figure 276: Molecular Ultrasound Imaging Molecular Imaging Market Forecast, 2017–2027
Figure 277: MEA Molecular Imaging Software Market Size Analysis, 2012–2016
Figure 278: MEA Molecular Imaging Software Market Forecast, 2017–2027
Figure 279: MEA Molecular Imaging Market Attractiveness Analysis By Modality, 2017–2027
Figure 280: MEA Cardiology Molecular Imaging Market Size Analysis, 2012–2016
Figure 281: MEA Cardiology Molecular Imaging Market Forecast, 2017–2027
Figure 282: MEA Oncology Molecular Imaging Market Size Analysis, 2012–2016
Figure 283: MEA Oncology Molecular Imaging Market Forecast, 2017–2027
Figure 284: MEA Gastrointestinal Disorders Molecular Imaging Market Size Analysis, 2012–2016
Figure 285: MEA Gastrointestinal Disorders Molecular Imaging Market Forecast, 2017–2027
Figure 286: MEA Neurology Disorders Molecular Imaging Market Size Analysis, 2012–2016
Figure 287: MEA Neurology Disorders Molecular Imaging Market Forecast, 2017–2027
Figure 288: MEA Other Molecular Imaging Market Size Analysis, 2012–2016
Figure 289: MEA Other Molecular Imaging Market Forecast, 2017–2027
Figure 290: MEA Molecular Imaging Market Attractiveness Analysis By Application, 2017–2027
Figure 291: MEA Hospital Molecular Imaging Market Size Analysis, 2012–2016
Figure 292: MEA Hospital Molecular Imaging Market Forecast, 2017–2027
Figure 293: MEA Ambulatory Surgical Center Molecular Imaging Market Size Analysis, 2012–2016
Figure 294: MEA Ambulatory Surgical Center Molecular Imaging Market Forecast, 2017–2027
Figure 295: MEA Diagnostics Imaging Center Molecular Imaging Market Size Analysis, 2012–2016
Figure 296: MEA Diagnostics Imaging Center Molecular Imaging Market Forecast, 2017–2027
Figure 297: MEA Molecular Imaging Market Attractiveness Analysis By End User, 2017–2027
Figure 298: Global Molecular Imaging Market Attractiveness Analysis By Region, 2017–2027
Figure 299: Global Molecular Imaging Market Attractiveness Analysis By Modality Type, 2017–2027
Figure 300: Global Molecular Imaging Market Attractiveness Analysis By Application, 2017–2027
Figure 301: Global Molecular Imaging Market Attractiveness Analysis By End User, 2017–2027
Figure 302: Global Molecular Imaging Market Value Analysis and Forecast, 2016–2027 (US$ Mn)
Figure 303: Global Molecular Imaging Market Absolute $ Opportunity (US$ Mn), 2012–2016
Figure 304: Global Molecular Imaging Market Absolute $ Opportunity (US$ Mn), 2016–2027
Get in touch
Harish Tiwari
Global Head - Business Development
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.